Tech Tour Announces the Top 20 Digital Health Companies and the Top 20 Medtech Companies in Europe

30 June - 1 July 2015, Lausanne, Switzerland.
The Tech Tour today announced the top 20 Digital Health companies and the top 20 Medtech companies in Europe. The 40 companies have been selected by two Selection Committees made up of Investors as well as representatives from Life Science companies. The selected companies will be presenting at the Healthtech Summit in Lausanne to an audience of over 200 people, including Venture and Private Equity investors collectively representing $40Bn in invested assets, Business Angels and Life Sciences companies, among whom the No 1 Pharma company, the No 1 food company and No 1 Med Tech company.

Close to 200 nominations were received, 123 companies have applied and the Selection Committees have spent several months rigorously screening and choosing the final 40. Companies were chosen according to the uniqueness of their solutions, the strength of their business model, their capability to execute on the business plan and the quality and track record of their management teams.

Of the top 40 companies, 4 are seed stage; 21 are start-ups; 14 are in expansion/growth stage and 1 company is late stage/pre-IPO. In terms of the countries represented the breakdown is as follows: Denmark (1); Finland (1); France (3); Germany (7); Ireland (1); Israel (1); Italy (1); Netherlands (1); Portugal (1); Spain (4); Sweden (1); Switzerland (10); UK (5).

The top 20 Digital Health Companies:
Better Doc, Biovotion, BrainControl, Coimbra Genomics, Dacadoo, Dermosafe, Doctoralia, Emperra, Exovite, Genexyx, Giraff, Healthbank, NeurNation, Nutrino, Psious, Px Healthcare, SilverCloud, Systems Healthcare Solutions, TrialReach, XtremeVRI.

The top 20 Medtech Companies:
Adaptix, Admetsys, Aeon Scientific, Atlas Genetics, Bone Index, coramaze, CorWave, DBS System, EasyScan, Lambda Health System, LimFlow, Medical Adhesive Revolution, Mensia, NanoLive, Newronika, Oncgnostics, PathMaker, Precision Ocular, Tissot Medical Research, Wise.

Speakers and panellists at the event include Ulrich Muehlner, Novartis, Valerio Nannini, Nestle, Bill Taranto and Joe Volpe, Global Health Innovation (Merck), Roberto Ascione, Razorfish Healthware, Martin Kelly, HealthXL, Toby Lewis, Global Corporate Venturing, Charity Kufaas, Medtronix, Angelo de Rosa, Boston Scientific, Janke Dittmer, Gilde Healthcare Partners, Bettina Experton, Humetrix and Victor Garcia, Mooreland Partners, as well asAlex Osterwalder, Strategyzer.

This year's Awards Ceremony will be held on June 30th at IMD with two award categories to recognize and celebrate excellence in health technology innovation. The new Canton de Vaud Digital Health Award will recognize one of the most promising innovative companies of the region with demonstrated market traction and fundraising. And this year's Salus Partners Excellence in Healthcare Award will go to the most successful company exit of the year among the 100+ Alumni of the HealthTech Summit.

For further information, please visit:
http://www.techtour.com/health_tech_summit_2015/

2015 Digital Health Selection Committee Members
Asset Management, Bessemer Venture Partners, Boston Scientific, DFJ Esprit, Endeavour Vision S.A., Gilde Healthcare Partners, Health XL, Index Ventures, Invesco Perpetual, Merck Global Health Innovation Fund, Medtronic Europe S.A., Mooreland Partners, Nestlé S.A., Norwest Venture Partners, Omega Funds, Orbimed Advisors, PHS Fund, Reed Elsevier Ventures, Samsung Electronics, SMR Capital, Startup Health.

2015 Medtech Selection Committee Members
Baycity Capital, Delta Partners Ltd., Earlybird Venture Capital, Endeavour Vision, Entrepreneurs Fund Management, Fountain Healthcare Partners, Imperial Innovations, NBGI Ventures, Omnes Capital, Salus Partners, Sofimac Partners Investment Capital, Sofinnova.

About The Tech Tour
The Tech Tour was founded in Geneva in 1998 in response to the growing interest in emerging technology companies in various European regions. The Tech Tour brings together investors and high-tech entrepreneurs through its highly successful events - Regional Tech Tours that cover multiple cities in a particular European region and Tech Summits that focus on a particular industry vertical. The Tech Tour focuses on selecting the highest quality companies for its events and as a result selected companies have been very successful in obtaining funding. The Tech Tour over the years has built a very strong and inter-connected community of Entrepreneurs, Investors, Government influencers, Industry experts and Advisers. This community comes together regularly to network, collaborate and to invest their time and money in furthering the high-tech innovation ecosystem in Europe.

About the International Venture Club
The International Venture Club was founded in 2011 as the collaborative platform of leading venture investors promoting successful international investments. Its objectives are to 1) share better practices, 2) build co-investor trust and relations, 3) foster new funding and investment opportunities through joint actions and PR, 4) grow promising companies with corporate partners and co-investors and 5) keep a smart window and support to emerging innovative companies.

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...